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ABSTRACT 
Diuretics are widely employed drugs used to treat extra cellular fluid volume expansion caused 
due to renal, cardiac, liver disorders etc. These diuretics are effective but have side effects. 
Acalypha Indica Linn is a herb of Euphorbiaceae family, found throughout India as a weed. Many 
studies have been carried out but sufficient data is not available to establish its diuretic activity. 
Hence the study is focused on the assessment of Harita Manjari for its diuretic action in animal 
model. 
Methods: The trial drugs are administered for 7 days prior to the day of evaluation of diuretic 
action; the rats were individually placed in the metabolic cages to collect urine. The volume of 
the urine collected in graduated vials was measured after 6 hours and expressed in terms of 
ml/100gm of body weight. 
Results: The invivo study demonstrated that crude suspension of Harita Manjari in a dose of 
450mg/kg has significant diuretic activity. 
The statistical analysis has been carried out and results on continuous measurements are 
presented on Mean ± SEM were calculated. Urine output, pH and urine electrolytes were 
compared with control groups by one-way ANOVA followed by Dunnett’s multiple comparison 
test. The P Value <0.05 were considered as statistically significant. 
Conclusion: Order of diuresis: Crude suspension >Alcoholic extract >Aqueous extract.  
KEYWORDS: Haritamanjari, Acalypha Indica, Mutrala, diuretics, Metabolic cage. 
INTRODUCTION 
Mutravirechaniya Dravyas are drugs which 
acts by promoting the flow of urine and cleanses 
Mutravaha Srotas without hampering the fluid 
balance and electrolytes. The homeostasis is 
hampered during condition like Mutrakrichra, 
Mutraghata, Ashmari, Shotha, and other urinary 
disorders. In such cases diuretics are used.[1,6,8] The 
modern therapeutics has high, moderate and low 
efficacy diuretics which are effective but have side 
effects like hyponatreia, hypokalemia, gout, 
hyperglycemia etc. 
So there is a need of a drug which fulfills the 
above criteria along with cost effectiveness and easy 
availability.[1] 
  Although various studies have been carried 
out with respect to various parts of Harita manjari 
plant but not much data is available to establish 
diuretic activity. 
There is no description regarding Harita 
manjari in any of the Bruhatrayis or laghuthrayis 
(treatises). 
First description regarding Harita manjari is 
mentioned in the text book of Vaidyamanoram evam 
dharakalpa[7], as one of the ingredient in Punarnavadi 
churna for Dantaroga (dental diseases) by 
Vaidyavara shri Kalidasa.  
Acharya Bhavamishra has mentioned 
Haritamanjari in Bhava prakasha nighantu[2] 
(Lexicon), as Kaphaghna, Mootrala, Vamaka 
Sramsana, Krimigna and Twak Doshahara under 
Parishishta Varga, drug no. 90. 
MATERIALS & METHODS 
Collection of the trial drugs: Dhanvantari vana, 
Bangalore University, Bangalore. 
Drug authentication: by Dr. Ganeshbabu Ph.D., 
Botanist, FRLHT, Yelahanka, Bangalore. 
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Preparation of the drugs: Harita manjari leaves 
washed and dried in shade then ground into fine 
powder.  
Preparation of the extract: Soxhlet Apparatus 
• Aqueous and Alcoholic (Ethanol) extracts by 
continuous hot extraction.  
• Extract obtained in the form of semisolid was 
stored in air tight container. 
Objectives of the Study 
• To evaluate Diuretic activity of Harita manjari 
(Acalypha Indica Linn) in animal model. 
Grouping 
Equipment: Orchid scientific metabolic cages  
Preparation and maintenance of cage: OECD 
Guidelines were followed 
Examination of the animals prior to the 
experiment: The animals were randomly selected 
and kept in their cages for at least 5 days prior to 
dosing to allow for acclimatization to the laboratory 
conditions. 
Mice: Polypropylene cages 9 with provision for water 
bottle holder and feed hopper with corn cobs as 
bedding material. 
Diet: ad libitum- Pelleted rodent feed (Teklad global, 
14% protein, maintenance feed).  
Water: ad libitum- Deep bore well water passed 
through charcoal filters and exposed to UV rays and 
water in polypropylene water bottles were provided 
to the animals.  
Identification: By cage card, crystal violet/picric 
acid color body marking.  
Route of Administration: Oral  
Vehicle for administration of drug: 2% gum acacia 
solution was used as vehicle. 
Treatment age: 7-8 weeks, weighing 100–200gm. 
Table: 1 Showing grouping of 30 rats 
 Group Drug 
1.  Control Group  Distilled water  
2.  Standard Group  Furosemide (10mg/kg 
body wt.)  
3.  Aqueous extract 
of Harita manjari  
200mg/kg body wt 
4.  Alcoholic extract 
of Harita manjari  
200mg/kg body wt 
5.  Crude form of 
Haritha manjari  
450mg/kg body wt 
Dose: Based on the API standards human dose of 
Churna (powder) is 3-6gm. Human Dose × Body 
surface area ratio convertibility factor (0.018)= ’x’ 
gms/200gm of rat. Thus crude drug dose was fixed to 
be 450mg. 
Experimental Trial Proper [5,9] 
SD rats weighing 100–200 g are used. On the 
day of starting of the drug treatment, the rats were 
individually placed in the metabolic cages to collect 
urine. The metabolic cages provided with a wire 
mesh bottom and a funnel to collect the urine. 
Stainless steel sieves are placed in the funnel to 
retain feces and to allow the urine to pass.  
Fifteen hours prior to the experiment food 
and water are withdrawn. For screening procedures 
5 groups of 6 animals are used for dose of the test 
compound.  
Task: collection of 6 hour urine output.  
The trial drugs were administered for 7 days prior to 
the day of evaluation of diuretic action.  
The volume of the urine collected in graduated vials 
was measured at the end of 6 hours and expressed in 
terms of ml/100gm of body weight. 
Parameters: Urine volume, Urine pH, Urine 
Electrolytes.
RESULTS AND DISCUSSION  




1  1.2  8.1  118.6  53.9  
2  1.5  8  121.3  58.4  
3  0.5  7.9  114.5  54.9  
4  1.4  7.8  116.2  59.7  
5  2.1  8  108.6  51.9  
6  2.2  8.2  110.8  54.7  
Mean   1.5  8.0  115.0  55.6  
SME   0.6  0.2  3.7  0.6  
Standard  
7  3.4  8.1  148.6  82.1  
8  2.6  8.2  157.6  84.6  
9  3.6  8.3  162.4  81.3  
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10  2  8.4  158.6  83.4  
11  3.5  8.1  154.9  85.7  
12  4  8.5  163.8  86.9  
Mean   2.0  8.4  141.5  72.4  
SME   0.6    0.1  3.2  0.3  
Aqueous Extract  
13  0.4  8  147.5  72.4  
14  4  7.9  142.7  71.6  
15  1.5  8.1  138.9  73.4  
16  2.2  9.1  151.7  72.9  
17  1.6  8.9  154.4  74.6  
18  0.3  9.2  164.2  75.8  
Mean   1.7  8.5  149.9  73.5  
SME   0.6  0.2  3.7  0.6  
Aloholic Extract  
19  0.5  8.2  139.4  71.9  
20  1  8  141.5  72.8  
21  2  8.2  136.7  71.5  
22  5  8.6  130.9  73  
23  1.5  8.9  147.6  71.8  
24  2  8.7  152.7  73.6  
Mean   2.0  8.4  141.5  72.4  
SME   0.6    0.1  3.2  0.3  
Crude Suspension 25  1.5  8  128.6  73.8  
26  1  8.2  118.4  68.4  
27  1.4  8.1  121.4  64.9  
28  1.5  8.9  134.1  72.5  
29  3.6  8.6  123.8  66.1  
30  4  9  110.9  61.2  
Mean   2.2  8.5  122.9  67.8  
SME   0.5    0.2  3.3  1.9  
Table 2: Results 
Parameter  Control  Standard  Aq.Extract  Al.Extract   Crude Suspension  
Urine volume  1.5  3.2  1.7  2.0  2.2  
Urine Ph  8  8.3  8.5  8.4  8.5  
Urine sodium in mmol/L  115  157.7  149.9  141.5  122.9  
Potassium in mmol/L  55.6  84  73.5  72.4  67.8  
Order of Diueresis 
Standard > Crude suspension > Alcoholic extract > Aqueous extract > Control 
Statistical Analysis 
Descriptive and inferential statistical analysis has been carried out in the present study Average of all 
the data were compiled and Results on continuous measurements are presented on Mean ± SEM were 
calculated. Urine output, pH and urine electrolytes were compared with control groups by one-way ANOVA 
followed by Dunnett’s multiple comparison test. Values <0.05 were considered as statistically significant. 
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It is mentioned that some drugs act by means 
of Rasa other by Veerya and other by Guna, Vipaka or 
Prabhava (innate properties of drug).  
In addition some substances either migrate or 
aggravate the Doshas by their own self (Dravya).  
Due to Basti Shodhaka and Mutrala properties 
these may eliminate the Mutra Visha (toxic wastes) 
and detoxifies the blood.  
Rasa Panchaka[6, 8] 
• Rasa- Kashaya Tikta Madhura  
• Guna- Laghu Ushna Ruksha  
• Veerya- Ushna  
• Vipaka- Katu  
• Prabhava- Vamaka Kaphaghna 
Bye the virtue of [3] 
Rasa 
Kashaya- Lekhana- Pitta kapha shamaka,  
Tikta- Deepana, Pachana, Lekhana- Pitta kapha 
shamaka, 
Madhura- Vishahara, Daha prashamana- Pitta 
shamaka. 
Guna 
Laghu- Lekhana, Kledaachushana, Uparopan-
Kaphavata shamaka. 
Ushna- Pachan, Kapha Vilayan- Kaphavata shamaka  
Ruksha-Uparopan- Kapha shamaka. 
Veerya 
Ushna veerya- Pachan, Kapha Vilayan- Kaphavata 
shamaka  
Vipaka 
Katu Vipaka- Acharya Chakrapaani comments on 
Charaka sutra 25th chapters 9-11th Shlokas that 
“Nishtapaaka malarupataya utpad” (during the 
second stage of metabolism Kapha and Pitta Doshas 
are increased in the form of metabolic wastes and not 
as aggravated Doshas). 
Phytoconstituents [10-12] 
Although Tannins, β-sitosterol, acalyphamide, 
aurantiamide, succinimide, triterpinoid, saponin are 
present, the following were the phytoconstituents 
that is responsible for the diuretic activity of 
Acalypha Indica. 
Sugar- Due to their osmotic activity these substances 
oppose the reabsorption of water from the 
glomerular filtrate. These substances produce more 
elimination of water than sodium, and hence produce 
diuresis  
Acalyphin- The aerial parts contain a cyanogenic 
glycoside called acalyphin (a 3-cyanopyridone 
derivative).  
Flavonoids- Such as kaempferol, glycosides, 
mauritianin, clitorin, nicotiflorin, and biorobin.  
Flindersin- A pyranoquinolinone alkaloid have also 
been isolated. 
Spironolactone- which is a diuretic steroid. 
Order of Diueresis In Trial Groups  
Crude suspension > Alcoholic extract > Aqueous 
extract.  
 The above order of activity indicates the presence 
phytochemical constituents in crude suspension 
which were probably absent when extracted with 
water and ethanol. 
  Further, successive extraction with solvents like 
chloroform and methanol (in the order of polarity) 
may result in extraction of phytoconstituents 
which may show better efficacy. 
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 In this study it was found that the crude drug 
suspension showed significant increase in urine 
output, sodium and potassium levels when 
compared against control and it was comparable 
to furosemide which was used as standard drug in 
the study.  
 Alcoholic and aqueous extracts also displayed 
diuretic activity as compared against control but 
did not appear to be significant.  
CONCLUSION 
The study demonstrated that crude drug 
suspension of Harita manjari in a dose of 450 mg/kg 
has significant diuretic activity. 
  Order of diuretic activity (Urine output)  
Crude suspension > Alcoholic extract > Aqueous 
extract.  
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